by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Intas Pharmaceuticals Limited Warning Letter Details

Warning Letter

Intas Pharmaceuticals Limited

Plot No. 255, Magnet Corporate Park Nr. Sola Bridge, S. G. Highway, Thaltej Ahmedabad India

Issue DateMarch 30, 2026

FEI Number3005890633

Violations2

CountryIndia

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Intas Pharmaceuticals Limited FDA Warning Letter, March 30, 2026